lobbying_activities: 3193911

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3193911	59253fd4-ef11-4ec2-911f-55836450818c	Q2	AARP	1694	AARP	2024	second_quarter	PHA	No bill number. Discussed out-of-pocket caps for prescription drugs. No bill number. Discussed pharmacy benefit manager reforms. H.R. 4818, the Treat and Reduce Obesity Act. No bill number. Discussed medication safety at home. No bill number. Discussed Medicare drug price negotiation program. No bill number. Discussed Medicare Prescription Payment Plan. S.79, the Interagency Patent Coordination and Improvement Act of 2023. S.142, the Preserve Access to Affordable Generics and Biosimilars Act of 2023. S.148, the Stop STALLING Act. S.150, the Affordable Prescriptions for Patients Act of 2023. S.113, the Prescription Pricing for the People Act of 2023. H.R. 5539/ S. 3131, Optimizing Research Progress Hope and New Cures Act. H.R. 5547/ S. 476, Maintaining Investments in New Innovation Act. H.R. 3549/ S. 1703, the PACE Part D Choice Act of 2023. No bill number. Discussed generic prescription drug shortages. S.2220/ H.R. 4370, the PREVAIL Act. No bill number. Discussed US Patent and Trade Office proposed rule. H.R. 8848, Affordable and Safe Prescription Drug Importation Act of 2024.	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office		5170000	0	0	2024-07-16T12:11:35-04:00